Detalhe da pesquisa
1.
Clinical features, prognostic stratification, and treatment of advanced-stage non-nasal type extranodal natural killer/T-cell lymphoma: a multi-institutional real-world study.
Ann Hematol
; 103(1): 163-174, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37817010
2.
Tislelizumab and radiation therapy in low-risk early-stage extranodal natural killer/T-cell lymphoma, nasal type: a phase II study protocol.
Future Oncol
; 20(5): 245-256, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38018460
3.
Multicenter phase II study of moderate low-dose radiotherapy in indolent non-Hodgkin lymphoma: CLCG-iNHL-01 protocol.
Future Oncol
; 20(2): 71-81, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38179936
4.
Intensive therapy can improve long-term survival in newly diagnosed, advanced-stage extranodal NK/T-cell lymphoma: A multi-institutional, real-world study.
Int J Cancer
; 153(9): 1643-1657, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37539660
5.
The prognostic value of tumour-infiltrating lymphocytes, programmed cell death protein-1 and programmed cell death ligand-1 in Stage I-III triple-negative breast cancer.
Br J Cancer
; 128(11): 2044-2053, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36966236
6.
Evidence of cure for extranodal nasal-type natural killer/T-cell lymphoma with current treatment: an analysis of the CLCG database.
Haematologica
; 108(9): 2467-2475, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36951150
7.
Risk stratification and prognostic value of multi-modal MRI-based radiomics for extranodal nasal-type NK/T-cell lymphoma.
BMC Cancer
; 23(1): 88, 2023 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36698118
8.
Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study.
Ann Hematol
; 102(9): 2459-2469, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37306711
9.
Treatment and prognosis of newly diagnosed advanced-stage extranodal natural killer / T cell lymphoma: a single-center real-world study across two decades.
Chemotherapy
; 2023 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37984344
10.
POstmastectomy radioThErapy in Node-posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a study protocol for a multicenter prospective phase III randomized controlled trial.
BMC Cancer
; 21(1): 1185, 2021 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34742270
11.
Radiotherapy plays an important role in improving the survival outcome in patients with T1-2N1M0 breast cancer - a joint analysis of 4262 real world cases from two institutions.
BMC Cancer
; 20(1): 1155, 2020 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33243177
12.
Risk-based, response-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group study.
Am J Hematol
; 95(9): 1047-1056, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32449800
13.
Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial.
Lancet Oncol
; 20(3): 352-360, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30711522
14.
A prospective phase II clinical trial of total neoadjuvant therapy for locally advanced gastric cancer and gastroesophageal junction adenocarcinoma.
Sci Rep
; 14(1): 7522, 2024 03 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38553594
15.
Optimizing the prognostic capacity of baseline 18F-FDG PET/CT metabolic parameters in extranodal natural killer/T-cell lymphoma by using relative and absolute thresholds.
Heliyon
; 10(3): e25184, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38322946
16.
Treatment outcome, toxicity, and quality of life of patients with bronchus-associated lymphoid tissue lymphoma.
Leuk Lymphoma
; : 1-12, 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38506231
17.
Disparities in mortality risk after diagnosis of hematological malignancies in 185 countries: A global data analysis.
Cancer Lett
; : 216793, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38513800
18.
Prediction of 5-year overall survival of diffuse large B-cell lymphoma on the pola-R-CHP regimen based on 2-year event-free survival and progression-free survival.
Cancer Med
; 2024 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38180169
19.
Survival benefit with salvage radiotherapy for patients with locoregionally recurrent extranodal NK/T cell lymphoma, nasal type.
Ann Hematol
; 92(3): 325-32, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23100164
20.
Favorable outcome with doxorubicin-based chemotherapy and radiotherapy for adult patients with early stage primary systemic anaplastic large-cell lymphoma.
Eur J Haematol
; 90(3): 195-201, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23301725